Akèy › Maladi Crohn › Oklahoma › Oklahoma City
Etid klinik pou Maladi Crohn nan Oklahoma City, OK
7 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- Digestive Disease Specialists Inc. ( Site 5117), Oklahoma City
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Ap rekriteFaz 2
- Digestive Disease Specialists - Oklahoma /ID# 265901, Oklahoma City
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Digestive Disease Specialists Inc, Oklahoma City
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Ap rekriteFaz 4
- Digestive Disease Specialists, Inc., Oklahoma City
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Digestive Disease Specialists Inc, Oklahoma City
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Ap rekriteFaz 3
- The University of Oklahoma Health Sciences Center, Oklahoma City
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ap rekriteFaz 3
- The University of Oklahoma Health Sciences Center, Oklahoma City
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Orlando, FL17 etid
- Houston, TX17 etid
- Atlanta, GA17 etid
- Tyler, TX16 etid
- San Diego, CA15 etid
- San Antonio, TX15 etid
- Los Angeles, CA15 etid
Lòt etid nan Oklahoma City
- Kansè Poumon ki pa ti selil28 etid
- Kansè ovè28 etid
- Kansè Endomèt25 etid
- Kansè kolorektal22 etid
- Kansè pwostat21 etid
- Kansè poumon19 etid
- Kansè nan tete17 etid
- Kansè Metastatik15 etid
- Kansè (tout kalite)14 etid
- Leksemi mieloïd egi14 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Kansè pankreyas11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.